Showing results (391-400 of 491) with videos related to
Sort By:
Pageof 50
Thrombosis and Haemostasis|January 10, 2014
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery diseaseDavid Erlinge, Stefan James, Suman Duvvuru, et al.Journal of Clinical Medicine|November 21, 2019
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE StudyBaba Psalm Duniya Inusa, Raffaella Colombatti, David C Rees, et al.Thrombosis and Haemostasis|September 7, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysOscar Ö Braun, Dominick J Angiolillo, Jose L Ferreiro, et al.British Journal of Haematology|December 12, 2018
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterationsRichard J Lin, Caleb Ho, Patrick D Hilden, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.European Heart Journal|May 14, 2009
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialAlan D Michelson, Andrew L Frelinger, Eugene Braunwald, et al.Transplantation and Cellular Therapy|December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation RecipientsGyuri Han, Anat Stern, Yeon Joo Lee, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Mary Pao, Esperanza B Papadopoulos, Joanne Chou, et al.Transplantation and Cellular Therapy|October 14, 2020
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisAndrew Lin, Jessica Flynn, Lauren DeRespiris, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.Pageof 50